Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

113.62
Delayed Data
As of Jan 19
 -1.60 / -1.39%
Today’s Change
93.05
Today|||52-Week Range
127.00
-1.84%
Year-to-Date

Today’s Trading

Previous close115.22
Today’s open115.07
Day’s range113.15 - 115.29
Volume4,701,297
Average volume (3 months)4,561,314
Market cap$89.3B
Dividend yield--
Data as of 4:00pm ET, 01/19/2017

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+25.71%
Earnings growth (next 5 years)+21.22%
Revenue growth (last year)+16.47%
P/E ratio43.2
Price/Sales11.10
Price/Book15.31

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.69-0.89%
BMYBristol-Myers Squibb-0.58-1.03%
GSKGlaxoSmithKline-0.14-0.36%
AGNAllergan-1.98-0.91%
Data as of 4:02pm ET, 01/19/2017

Financials

Next reporting dateJanuary 26, 2017
EPS forecast (this quarter)$1.59
Annual revenue (last year)$8.9B
Annual profit (last year)$1.6B
Net profit margin18.00%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Mark J. Alles
President, Chief Operating Officer &
Director
Jacqualyn A. Fouse
Corporate headquarters
Summit, New Jersey

Forecasts


Search for Jobs